PMID: 6112327Apr 25, 1981Paper

Hepatoerythropoietic porphyria: a new uroporphyrinogen decarboxylase defect or homozygous porphyria cutanea tarda?

Lancet
G H ElderR E De Salamanca

Abstract

Uroporphyrinogen decarboxylase levels were measured in haemolysed whole blood or fibroblasts from 3 unrelated patients with hepatoerythropoietic porphyria (HEP) and in 4 unrelated patients with familial porphyria cutanea tarda, a condition in which the enzyme is defective. In HEP patients enzyme activities were 7% of normal in erythrocytes and 8% of normal in cultured skin fibroblasts. All the features of HEP, including the characteristic accumulation of protoporphyrin in erythrocytes, are secondary to this enzyme defect. The father of 1 HEP patient was heterozygous for the same enzyme defect. He also had uroporphyrinuria and was therefore indistinguishable from patients with subclinical familial porphyria cutanea tarda. It is suggested that patients with HEP are homozygous for the gene that causes porphyria cutanea tarda.

References

Dec 4, 1976·Lancet·G H ElderN Thomas
Dec 1, 1977·The British Journal of Dermatology·G Topi, L D'Alessandro Gandolfo
Feb 16, 1978·The New England Journal of Medicine·A V BenedettoJ S Taylor
Aug 10, 1978·The New England Journal of Medicine·G H ElderJ A Tovey
Oct 31, 1978·Human Genetics·H de VerneuilY Nordmann
Jun 1, 1977·The British Journal of Dermatology·N SimonI Schneider
Jul 1, 1973·Acta paediatrica Scandinavica·F HofstadL Eriksen
Jun 1, 1974·Scandinavian Journal of Clinical and Laboratory Investigation·L Eriksen, N Eriksen
Jun 1, 1967·The Australasian Journal of Dermatology·W W Gunther
Apr 1, 1969·The British Journal of Dermatology·J P AguadéJ Rodés
Apr 3, 1980·The New England Journal of Medicine·D A Brenner, J R Bloomer
Jan 1, 1980·The International Journal of Biochemistry·R Enríquez de SalamancaV Mas

❮ Previous
Next ❯

Citations

Jan 1, 1990·International Journal of Cell Cloning·S Sassa
Apr 1, 1995·Journal of Bioenergetics and Biomembranes·G H Elder, A G Roberts
May 1, 1996·Mammalian Genome : Official Journal of the International Mammalian Genome Society·C WuR J Desnick
Jul 30, 1993·Clinica Chimica Acta; International Journal of Clinical Chemistry·J T Hindmarsh
Jan 1, 1986·The International Journal of Biochemistry·P KotalV Kordac
Jan 1, 1986·The International Journal of Biochemistry·A M BatlleA M Stella
Oct 9, 2002·Clinica Chimica Acta; International Journal of Clinical Chemistry·Yves Nordmann, Hervé Puy
Jun 1, 1989·Clinical Biochemistry·G H ElderR E de Salamanca
Apr 14, 1984·Lancet·V KordaJ Holub
Apr 14, 1984·Lancet·R W Fuller
Apr 29, 1998·Clinics in Dermatology·M B Poh-Fitzpatrick
Dec 6, 2000·The Australasian Journal of Dermatology·N R Bleasel, G A Varigos
Jun 1, 1984·Proceedings of the National Academy of Sciences of the United States of America·P H RomeoM Goossens
Feb 1, 1990·The British Journal of Dermatology·P G NorrisJ L Hawk
Apr 1, 1991·European Journal of Clinical Investigation·M RomanaP H Romeo
Nov 1, 1987·Pediatric Dermatology·S BundinoL D'Allessandro Gandolfo
Sep 1, 1994·Pediatric Dermatology·J L ParsonsG S Pai
Aug 17, 2006·International Journal of Dermatology·Gianfranco Biolcati, Carla Dolazza
Mar 23, 2017·International Journal of Dermatology·Nancy S HandlerRobert A Schwartz
Mar 1, 1996·Journal of the American Academy of Dermatology·R P Sarkany, T M Cox
Jun 29, 2018·Journal of the European Academy of Dermatology and Venereology : JEADV·R BaranP Aguilera
Jun 1, 1983·The British Journal of Dermatology·G H Elder
Dec 1, 1984·The Australasian Journal of Dermatology·M RogersV Poulos
Aug 1, 1983·European Journal of Clinical Investigation·D J ViljoenS Kramer
Nov 1, 1992·American Journal of Medical Genetics·A Fujimoto, J L Brazil
Jun 15, 2011·The British Journal of Dermatology·J To-FiguerasC Herrero
Apr 23, 2013·Annals of Clinical Biochemistry·S D Whatley, M N Badminton
Jul 2, 2015·Current Protocols in Human Genetics·Vaithamanithi-Mudumbai Sadagopa Ramanujam, Karl Elmo Anderson
Nov 1, 1987·Clinical Genetics·P MustajokiR Norio
Aug 1, 1992·International Journal of Dermatology·D A Paslin
Apr 1, 1990·The Journal of Dermatology·A M MuniesaJ M Mascaró
Sep 5, 2002·Photodermatology, Photoimmunology & Photomedicine·R P E Sarkany
Dec 1, 1990·Annals of Medicine·Y NordmannB Grandchamp
Jan 1, 1984·International Journal of Dermatology·P B DislerL Eales

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.